Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natural saline is an isotonic sodium chloride solution used as an inhaled placebo control in the ERASE trial (NCT06093191), a Phase 4 study conducted by Shanghai Pulmonary Hospital. In this multicenter, randomized, double-blind trial, the saline is administered via an ultrasonic nebulizer at a dose of 5ml twice daily for a duration of 12 weeks. The study is designed to evaluate the efficacy and safety of tobramycin inhalation solution, either alone or in combination with oral ciprofloxacin, for the eradication of *Pseudomonas aeruginosa* in adult patients with bronchiectasis who have a new or first isolation of the pathogen. As a placebo, the natural saline serves as an inactive comparator to establish the baseline for spontaneous clearance and to assess the therapeutic superiority of the active antimicrobial regimens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on natural saline.